First-Line Pharmacological Treatment of Post-herpetic Neuralgia

Clinical Scenario

Post-herpetic neuralgia (PHN) is persistent neuropathic pain that continues after a herpes zoster episode. Establishing an appropriate first-line pharmacological strategy is the central decision in early management.

Treatment Approach

First-line management is based on pharmacological monotherapy. The approach draws from a small set of well-established drug classes for neuropathic pain — with the choice between them guided by pain severity, affected body area, and individual patient factors. A topical option is also recognised as first-line in certain presentations.

Treatment goal: ≥50% reduction in neuropathic pain intensity

Instant Access to Structured Evidence-Based Regimens

References

Gabapentinoids, tricyclic anti-depressants and, in some circumstances, lidocaine 5% patches, are considered first-line medications.
There is no single gold standard for the treatment of PHN, and the methods with the greatest effectiveness are characterized by a significant reduction in pain intensity of at least 50% in less than half of patients.

View source ↗